Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 14 of 35
iControl Chronic Kidney Disease
NCT03951363
Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
NCT03435380
A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP)
NCT03823651
Harnessing Sleep/Circadian Rhythm Data as a Biomarker to Mitigate Health Risks
NCT03843762
Implementation Program to Improve CHG Bathing Compliance
NCT03898115
ED90 for Hyperbaric Bupivacaine in Super Obese Parturients
NCT03781388
ClinRO Sedation Validation
NCT03956342
Mindfulness Meditation in Glioma Patients
NCT03915912
Addressing Palliative Care Needs Among Intensive Care Unit Family Members
NCT03506438
Trial of Rifaximin in Probable Alzheimer's Disease
NCT03856359
Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation
NCT03719144
Impact of Reduced Cannabis Use on Functional Outcomes
NCT03681353
Heated Humidified Breathing Circuit Rewarming in Hypothermic Post Cardiopulmonary Bypass Patients.
NCT03697122
A Trial Assessing the Safety and Feasibility of Respiratory Muscle Training and Exercise Training in Children and Adolescents With Persistent Asthma
NCT03911206
DeStress for Health: Partnering With Granville and Vance Counties to Reduce Stress and Cancer Risk
NCT03776890
ED90 of 3% Chloroprocaine for Cervical Cerclage
NCT03805438
Emotion Regulation and Emotion Perception
NCT03790878
Seizure Prophylaxis in Patients With Glioma or Brain Metastasis
NCT03436433
Walking Gait Biomechanics Following Knee Joint Effusion
NCT03805464
Using Neuroscience to Optimize Digital Health Interventions Across Adulthood
NCT03744052
Adenosine Contrast CorrELations in Evaluating RevAscularizaTION
NCT03557385
Genicular Nerve Block for Total Knee Arthroplasty
NCT03706313
Blood Flow Restriction Concussion
NCT03695042
Desipramine in Infantile Neuroaxonal Dystrophy (INAD).
NCT03726996
A Survivorship Care Plan and Embedded Navigation Tool
NCT03424837
Long-term Antipsychotic Pediatric Safety Trial
NCT03522168
SDH of HPV Vaccine Completion
NCT03709602
Peer Support Dyads in Churches
NCT03463941
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784
Impact of Combined Medication and Behavioral Treatment for ASD & ADHD
NCT03242772
A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness
NCT03741322
Study of Pediatric Migraine: The Pediatric Migraine Registry
NCT03742024
Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)
NCT03726268
Contribution of Urethral Sensory Feedback in Voiding Efficiency
NCT03637582
Acute Exercise Effects in Obese Pregnancy
NCT03750695
INTERVAL: Ipilimumab and Nivolumab Combination Therapy: A Study of a Supervised or Semi-Supervised Exercise InteRVention or Usual Care With Functional Capacity and Quality of Life Evaluations in Subjects With Advanced or Metastatic RenAL Cell Carcinoma
NCT03692338
Association Between Activity and PROMIS Pediatric Measures in Children With Asthma
NCT03933540
OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers
NCT03531853
Coherence Imaging of the Cervical Epithelium With Scanning a/LCI
NCT03502798
Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina
NCT03253211
Implementation and Evaluations of Sepsis Watch
NCT03655626
Testing a Neurocognitive Model of Distancing Using Transcranial Magnetic Stimulation.
NCT03698591
Digital Supportive Care Awareness & Navigation
NCT03628794
Calming Alternatives Learned During MRI-Guided Breast Biopsy
NCT03877146
Reactions to Warnings on Hookah Ads
NCT03723616
Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)
NCT03167619
Communication Coaching to Improve Patient and Clinician Satisfaction in Cardiology Encounters
NCT03464110
Extra Layer Of Support
NCT03532997
Study of ALS Reversals 4: LifeTime Exposures
NCT03706391
OCT Pilot in Esophagus
NCT03434834
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.